Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation

AIDS Research and Human Retroviruses

Volumn 12, Issue 14, 1996, Pages 1305-1313

  Hart, Timothy K ^a   Truneh, Alemseged ^a   Bugelski, Peter J ^a,b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; SYNCYTIUM; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS INFECTIVITY;

EID: 0029793719     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1305     Document Type: Article

References (87)

1. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, and Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 1984;312:763-767.
2. Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, Terwilliger E, Dayton A, Rosen C, Haseltine WA, and Sodroski J: Functional regions of the human immunodeficiency virus envelope glycoprotein. Science 1987;237:1351-1355.
3. Lifson JD, Finberg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Steimer KS, and Engleman EG: Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope by glycoprotein. Nature (London) 1986;323:725-728.
4. Lifson JD, Reyes GR, McGrath MG, Stein BS, and Engleman EG: AIDS retrovirus induced cytopathology: Giant cell formation and involvement of CD4 antigen. Science 1986;232:1123-1127.
5. + cells by a complex of the 110K viral protein and the T4 molecule. Science 1986;231:382-385.
6. Eiden LE, and Lifson JD: HIV interactions with CD4: A continuum of conformations and consequences. Immunol Today 1992;13:201-206.
7. McKeating JA, Cordell J, Dean CJ, and Balfe P: Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 1992;191:732-742.
8. Sattentau QJ, and Moore JP: Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991;174:407-415.
9. Allan JS: Receptor-mediated activation events in HIV/SIV viral entry. In: AIDS Research Review, Vol. 2. Koff W, Wong-Staal F, and Kennedy RC (Eds.). Marcel Dekker, New York, 1991, pp. 133-156.
10. agm envelope glycoprotein heterodimers: possible role in receptor-mediated activation. AIDS Res Hum Retroviruses 1992;8:2011-2020.
11. Clapham PR, McKnight A, and Weiss RA: Human immunodeficiency virus type 2 infection and fusion CD4-negative human cell lines: induction and enhancement by soluble CD4. J Virol 1992;66:3531-3537.
12. Sekigawa I, Chamow SM, Groopman JE, and Byrn RA: CD4-immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells. J Virol 1990;64:5194-5198.
13. Bosch ML, Earl PL, Fargnoli K, Picciafuoco S, Giombini F, Wong-Staal F, and Franchini G: Identification of the fusion peptide of primate immunodeficiency viruses. Science 1989;244:694-697.
14. Slepushkin VA, Andreev SM, Sidorova MV, Melikyan GB, Grigoriev VB, Chumakov VM, Grinfeldt AE, Manukyan RA, and Karamov EV: Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function. AIDS Res Hum Retroviruses 1992;8:9-18.
15. Freed EO, Myers DJ, and Risser R: Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci USA 1990;87:4650-4654.
16. McClure MO, Marsh M, and Weiss RA: Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J 1988;7:513-518.
17. Sinangil F, Loyter A, and Volsky DJ: Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching. FEBS Lett 1988;239:88-92.
18. Stein BS, Gowda SD, Lifson JD, Penhallow RC, Bensch KG, and Engleman EG: pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 1987;49:659-668.
19. Dimitrov DS, Hillman K, Manischewitz J, Blumenthal R, and Golding H: Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein. J Virol 1992;66:132-138.
20. Moebius U, Clayton LK, Abraham S, Harrison SC, and Reinherz EL: The human immunodeficiency virus gp120 binding site on CD4: Delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure. J Exp Med 1992;76:507-517.
21. Moore JP, Klasse PJ: Thermodynamic and kinetic analysis of sCD4 binding to HIV-1 virions and of gp120 dissociation. AIDS Res Hum Retroviruses 1992;8:443-449.
22. Thali M, Olshevsky U, Furman C, Gabuzda D, Li J, and Sodroski J: Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity. J Virol 1991;65:5007-5012.
23. Fu Y-K, Hart TK, Jonak ZL, and Bugelski PJ: Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. J Virol 1993;67:3818-3825.
24. Kinchington D, Barker W, Galpin S, and Apostolov K: Temperature enhancement of syncytium formation by HIV and Sendai virus. J Med Virol 1992;36:44-48.
25. Dimitrov DS, Willey RS, Martin MA, and Blumenthal R: Kinetics of HIV-1 interactions with sCD4 and CD4+ cells: Implications for inhibition of virus infection and initial steps of virus entry into cells. Virology 1992;187:398-406.
26. Jonak ZL, Clark RK, Matour D, Trulli S, Craig R, Henri E, Lee EV, Greig R, and Debouck C: A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope. AIDS Res Hum Retroviruses 1993;9:23-32.
27. Healey DG, Dianda L, Buck D, Schroeder K, Truneh A, Sattentau QJ, and Beverley PCL: A highly selected panel of anti-CD4 antibodies fails to induce anti-idiotypic antisera mediating human immunodeficiency virus neutralization. Eur J Immunol 1991;21: 1491-1498.
28. Truneh A, Buck D, Cassatt DR, Juszczak R, Kassis S, Ryu SE, Healey D, Sweet R, and Sattentau Q: A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J Biol Chem 1991;266: 5942-5948.
29. Newman R, Alberts J, Anderson D, Camer K, Heard C, Norton F, Raab R, Reff M, Shuey S, and Hanna N: "Primatization" of recombinant antibodies for immunotherapy of human diseases: A macaque/human chimeric antibody against human CD4. Biotechnology 1992;10:1455-1460.
30. Deen KC, McDougal JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Axel R, and Sweet RW: A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature (London) 1988;331:82-84.
31. Dimitrov DS, Broder CC, Berger EA, and Blumenthal R: Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction. J Virol 1993;67:1647-1652.
32. Sattentau QJ, and Moore JP: The role of CD4 in HIV binding and entry. Phil Trans Roy Soc Lond Ser B Biol Sci 1993;342:59-66.
33. Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, and Capon DJ: Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987; 50:975-985.
34. Ryu SE, Truneh A, Sweet RW, and Hendrickson WA: Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. Structure 1994;2:59-74.
35. Callahan LN, Roderiquez G, Mallinson M, and Norcross MA: Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4. J Immunol 1992;149:2194-2202.
36. Szabo G Jr, Pine PS, Weaver JL, Rao PE, and Aszalos A: CD4 changes conformation upon ligand binding. J Immunol 1992; 149:3596-3604.
37. Sattentau QJ, Moore JP, Vignaux F, Traincard F, and Poignard P: Conformational changes induced in the envelope glycoproieins of the human and simian immunodeficiency viruses by soluble receptor binding. J Virol 1993;67:7383-7393.
38. Walker L, Wilks D, O'Brien J, Habeshaw J, and Dalgleish A: Localized conformational changes in the N-terminal domain of CD4 identified in competitive binding assay of monoclonal antibodies and HIV-1 envelope glycoprotein. AIDS Res Hum Retroviruses 1992;8:1083-1090.
39. Kang CY, Hariharan K, Posner MR, and Nara P: Identification of a neutralizing epitope conformationally affected by the attachment of CD4 to gp120. J Immunol 1993;151:449-457.
40. + cells. J Virol 1992;66:4784-4793.
41. Pinter A, Honnen WJ, and Tilley SA: Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with env processing and with binding of ligands to these sites. J Virol 1993;67:5692-5697.
42. Reed J, and Kinzel V: Inhibitors of the conformational switch involved in CD4 binding and by the env glycoprotein from human immunodeficiency virus type 1. Biochemistry 1994;33: 10993-10998.
43. Thali M, Moore JP, Furman C, Charles M, Ho DD, Robinson J, and Sodroski J: Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 1992;67:3978-3988.
44. Scullion BF, Hou Y, Puddington L, Rose JK, and Jacobson K: Effects of mutations in three domains of the vesicular stomatitis viral glycoprotein on its lateral diffusion in the plasma membrane. J Cell Biol 1987;105:69-75.
45. Anderson CM, Georgiou GN, Morrison IEG, Stevenson GYW, and Cherry RJ: Tracking of cell surface receptors by fluorescence digital imaging microscopy using a charge-coupled device camera. Low-density lipoprotein and influenza virus receptor mobility at 4°C. J Cell Sci 1992;101:415-125.
46. Manara FS, and Schneider DL: The activation of the human neutrophil respiratory burst occurs only at temperatures above 17°C: Evidence that activation requires membrane fusion. Biochem Biophys Res Commun 132:696-701.
47. Marsh M, and Helenius A: 1980. Adsorptive endocytosis of Semliki Forest virus. J Mol Biol 1980;142:439-454.
48. Clements GJ, Price-Jones MJ, Stephens PE, Sutton C, Schulz TF, Clapham PR, McKeating JA, McClure MO, Thomson S, Marsh M, Kay J, Weiss RA, and Moore JP: The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: A possible function in viral fusion? AIDS Res Hum Retroviruses 1991;7:3-16.
49. Kido H, Fukutomi A, and Katunuma N: A novel membrane bound serine esterase in human T4(+)-lymphocytes is a binding protein of envelope glycoprotein gp120 of HIV-1. Biomed Biochim Acta 1991;50:781-789.
50. Johnson ME, Lin Z, Padmanabhan K, Tulinsky A, and Kahn M: Conformational rearrangements required of the V3 loop of HIV-1 gp120 for proteolytic cleavage and infection. FEBS Lett 1994;337:4-8.
51. Werner A, and Levy JA: Human immunodeficiency virus Type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4. J Virol 1990;67:2566-2574.
52. Broder CC, Dimitrov DS, Blumenthal R, and Berger EA: The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology 1993;193:483-491.
53. Burkly LC, Olson D, Shapiro R, Winkler G, Rosa JJ, Thomas DW, Williams C, and Chisolm P: Inhibition of HIV infection by a novel CD4 domain 2 specific antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol 1992; 149:1779-1787.
54. Berman PW, and Nakamura GR: Adhesion mediated by intracellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation. AIDS Res Hum Retroviruses 1994;10:585-593.
55. Butini L, De Fougerolles AR, Vaccarezza M, Graziosi C, Cohen DI, Montroni M, Springer TA, Pantaleo G, and Fauci AS: Intercellular adhesion molecules (ICAM)-1 ICAM-2 and ICAM-3 function as counter-receptors for lymphocytes function molecule 1 in human immunodeficiency virus-mediated syncytia formation. Eur J Immunol 1994;24:2191-2195.
56. Golding H, Dimitrov DS, and Blumenthal R: LFA-1 adhesion molecules are not involved in the early stages of HIV-1 env-mediated cell membrane fusion. AIDS Res Hum Retroviruses 1992;8: 1593-1598.
57. Vermot-Desroches C, Rigal D, Escaich S, Bernaud J, Pichoud C, Lamelin JP, and Trepo C: Functional epitope analysis of the human CD11a/CD18 molecule (LFA-1, lymphocyte function associates antigen 1) involved in HIV-1-induced syncytium formation. Scand J Imrnunol 1991;34:461-470.
58. Busso M, Thornwaite J, and Resnick L: HIV-induced syncytia formation requires the formation of conjugates between virus-infected and uninfected T-cells in vitro. AIDS 1991;5:1425-1432.
59. Bridges CG, Brennan TM, Taylor DL, McPherson M, and Tyms AS: The prevention of cell adhesion and the cell-to-cell spread of HIV-1 in vitro by the alpha-glucosidase 1 inhibitor, 6-O-butanoyl catanospermine (MDL 28574). Antiviral Res 1994;25:169-175.
60. Lazaro I, Naniche D, Signoret N, Bernard AM, Marguet D, Klantmann D, Dragic T, Alizon M, and Sattentau Q: Factors involved in the entry of human immunodeficiency virus type 1 into permissive cells: Lack of evidence of a role for CD26. J Virol 1994;68:6535-6546.
61. Anderson WD, Fink AL, Perry LJ, and Wetzel R: Effects of an engineered disulfide bond on the folding of T4 lysozyme at low temperatures. Biochemistry 1990;29:3331-3337.
62. Roe JH, Burgess RR, and Record MT Jr: Temperature dependence of the rate constants of the Escherichia coli RNA polymerase-lambda PR promoter interaction. Assignment of the kinetics steps corresponding to protein conformational changes and DNA opening. J Mol Biol 1985;184:441-453.
63. Schwarz KR, Lanier SM, Sena LM, Carter EA, Graham RM, and Homey CJ: Agonist induced isomerization of the alpha 1-adrenergic receptor: Kinetic analysis using broken-cell and solubilized preparations. Biochemistry 1986;25:2697-2702.
64. Thomson JA, Shirley BA, Grimsley GR, and Pace CN: Conformational stability and mechanism of folding of ribonucleasee T1. J Biol Chem 1989;264:11614-11620.
65. Barnes JA: Conformation and stability of Sendai virus fusion protein. Int J Biol Macromol 1989;11:130-136.
66. Monsma SA, and Blissard GW: Identification of a membrane fusion domain and an oligomerization domain in the baculovirus GP64 envelope fusion protein. J Virol 1995;69:2583-2595.
67. Swift AM, and Chamer CE: A Golgi retention signal in a membrane-spanning domain of corona virus El protein. J Cell Biol 1991;115:19-30.
68. Takahashi S: Conformation of membrane fusion-active 20-residue peptides with or without lipid bilayers. Implication of alpha-helix formation for membrane fusion. Biochemistry 1990;29: 6257-6264.
69. Gordon LM, Curtain CC, Zhong YC, Kirkpatrick A, Mobley PW, and Waring AJ: The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation. Biochim Biophys Acta 1992;1139:257-274.
70. Martin I, Defrise-Quertain F, Decroly E, Vandenbraden M, Brasseur R, and Ruysschaert JM: Orientation and structure of the NH-terminal HIV-1 gp41 peptide in fused and aggregated liposomes. Biochim Biophys Acta 1993;1145:124-133.
71. Poumbourios P, el Ahmar W, McPhee DA, and Kemp BE: Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J Virol 1995;69:1209-1218.
72. Horth M, Lambrecht B, Khim MC, Bex F, Thiriart C, Ruysschaert JM, Burny A, and Brasseur R: Theoretical and functional analysis of the SIV fusion peptide. EMBO J 1991;10:2747-2755.
73. Voneche V, Portelle D, Kettmann R, Willems L, Limbach K, Paoletti E, Ruysschaert JM, Burny A, and Brasseur R: Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediated fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc Natl Acad Sci USA 1992;89:3810-3814.
74. de Cuevas M, Tao T, and Goldstein LS: Evidence that the stalk of Drosophila kinesin heavy chain is an alpha-helical coiled coil. J Cell Biol 1992;116:957-965.
75. Czisch M, Schleicher M, Harger S, Voelter W, and Holak TA: Conformation of thymosin beta 4 in water determined by NMR spectroscopy. Eur J Biochem 1993;218:335-344.
76. Morton LF, Peachey AR, Zijenah LS, Godall AH, Humphries MJ, and Barnes MJ: Conformation-dependent platelet adhesion to collagen involving integrin alpha 2 beta 1-mediated and other mechanisms: multiple alpha 2 beta 1-recognition sites in collagen type 1. Biochem J 1994;299:791-797.
77. Nir S, Klappe K, and Hoekstra D: Kinetics and extent of fusion between Sendai virus and erythrocyte ghosts: Application of a mass action kinetic model. Biochemistry 1986;25:2155-2166.
78. 125I-iodonaphthylazide. J Biol Chem 1994;269:14614-14619.
79. Berger EA, Lifson JD, and Eiden LE: Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: Implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc Natl Acad Sci USA 1991;88:8082-8086.
80. Hart TK, Kirsh R, Ellens H, Sweet RW, Lambert DM, Petteway SR, Leary J, and Bugelski PJ: Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc Natl Acad Sci USA 1991;88:2189-2193.
81. Kirsh R, Hart TK, Ellens H, Miller J, Petteway SA, Lambert DM, Leary J, and Bugelski PJ: Morphometric analysis of recombinant soluble CD4 mediated release of the envelope glycoprotein gp120 from HIV-1. AIDS Res Hum Retroviruses 1990;6:1215-1218.
82. Moore JP, McKeating JA, Weiss RA, and Sattentau QJ: Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 1990;250:1139-1142.
83. Marshall WL, Diamond DC, Kowalski MM, and Finberg RW: High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants. J Virol 1992;66: 5492-5499.
84. Thali M, Furman C, Helseth E, Repke H, and Sodroski J: Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events. J Virol 1992;66:5516-5524.
85. Frey S, Marsh M, Gunther S, Pelchen-Matthews A, Stevens P, Ortlepp S, and Stegman T: Temperature dependence of cell-cell fusion by the envelope glycoprotein of human immunodeficiency virus type 1. J Virol 1995;69:1462-1472.
86. Pedroso de Lima MC, Ramalho-Santos J, Martins MF, Pato de Carvalho A, Bairs V, and Nir S: Kinetic modeling of Sendai virus fusion with PC-12 cells. Effect of pH and temperature on fusion and viral inactivation. Eur J Biochem 1992;205:181-186.
87. Rhamalho-Santos J, Nir S, Duzgunes N, de Carvalho AP, and da C de Lima M: A common mechanism for influenza virus fusion activity and inactivation. Biochemistry 1993;32:2771-2779.